Cargando…
Targeting cancer stem cells in cholangiocarcinoma (Review)
The incidence of cholangiocarcinoma has been increasing steadily over the past 50 years, but the survival rates remained low due to the disease being highly resistant to non-surgical treatment interventions. Cancer stem cell markers are expressed in cholangiocarcinoma, suggesting that they serve a s...
Autores principales: | McGrath, Nicole A., Fu, Jianyang, Gu, Sophie Z., Xie, Changqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7307587/ https://www.ncbi.nlm.nih.gov/pubmed/32468022 http://dx.doi.org/10.3892/ijo.2020.5074 |
Ejemplares similares
-
Immunotherapy of hepatocellular carcinoma with infection of hepatitis B or C virus
por: Bonilla, Cecilia Monge, et al.
Publicado: (2020) -
Systemic treatment options for advanced biliary tract carcinoma
por: Xie, Changqing, et al.
Publicado: (2020) -
Characterization of Immunogenicity of Malignant Cells with Stemness in Intrahepatic Cholangiocarcinoma by Single-Cell RNA Sequencing
por: Bian, Jing, et al.
Publicado: (2022) -
Immune Checkpoint Inhibitor Associated Hepatotoxicity in Primary Liver Cancer Versus Other Cancers: A Systematic Review and Meta‐Analysis
por: Fu, Jianyang, et al.
Publicado: (2021) -
Single-cell RNA sequencing reveals cancer stem-like cells and dynamics in tumor microenvironment during cholangiocarcinoma progression
por: Golino, Jihye L., et al.
Publicado: (2023)